← European Medicine Shortage Tracker · all medicines
Docetaxel currently has availability issues reported in 4 European registers: Austria, Spain, Greece, Italy.
Shortage ATC L01CD02 · also listed as: DOCETAXEL · data refreshed 7 August 2026
As of 7 August 2026, 4 of the 10 tracked registers list current availability issues for Docetaxel, covering 13 affected product presentations. The longest-running open report was filed in Italy on 2025-10-03 and has now been open for about 10 months. Where agencies state a cause, manufacturing problems lead with 3 of the 4 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2026-12-14; the earliest is 2026-08-18. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 8 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2025-10-03), with Greece following roughly 10 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Greece, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Docetaxel is coded L01CD02 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇺 EU-wide (EMA) | Resolved Taxotere (docetaxel) | 2016-05-19 | — | Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Stomach Neoplasms;Breast Neoplasms Alternatives: EMA lists available alternatives — see the EMA record. | register ↗ |
| 🇦🇹 Austria | Shortage Docetaxel Accord 160 mg/8 ml Konzentrat zur Herstellung einer Infusionslösung + 1 more productsDocetaxel Accord 80 mg/4 ml Konzentrat zur Herstellung einer Infusionslösung | 2026-06-26 | — | — | register ↗ |
| 🇪🇸 Spain | Shortage DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 1 ml + 3 more productsDOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml DOCETAXEL HIKMA 160 MG/8 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml DOCETAXEL HIKMA 80 MG/4 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 2026-02-24 | 2026-08-30 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇬🇷 Greece | Limited availability BTx1VIALx16ML (160MG/16ML) + 1 more productsBTx1VIALx8ML (80MG/8ML) | 2026-08-24 | 2026-12-14 | PFIZER ΕΛΛΑΣ Α.Ε. Αυξημένη ζήτηση περιεκτικότητας Alternatives: Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και | register ↗ |
| 🇮🇹 Italy | Shortage DOCETAXEL ACCORD + 4 more productsDOCETAXEL ACCORD DOCETAXEL AUROBINDO DOCETAXEL AUROBINDO DOCETAXEL AUROBINDO | 2025-10-03 | 2026-07-21 | Problemi regolatori Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Docetaxel in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | BTx1VIALx8ML (80MG/8ML) | Limited availability | 2026-09-24 | 2026-12-14 | PFIZER ΕΛΛΑΣ Α.Ε. Αυξημένη ζήτηση περιεκτικότητας |
| 🇬🇷 GR | BTx1VIALx16ML (160MG/16ML) | Limited availability | 2026-08-24 | 2026-12-14 | PFIZER ΕΛΛΑΣ Α.Ε. Αυξημένη ζήτηση περιεκτικότητας |
| 🇮🇹 IT | DOCETAXEL AUROBINDO | Shortage | 2026-08-12 | — | Problemi produttivi |
| 🇪🇸 ES | DOCETAXEL HIKMA 80 MG/4 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EF | Shortage | 2026-06-29 | 2026-08-18 | Existen otros medicamentos con los mismos principios activos |
| 🇦🇹 AT | Docetaxel Accord 160 mg/8 ml Konzentrat zur Herstellung einer Infusion | Shortage | 2026-06-26 | — | |
| 🇦🇹 AT | Docetaxel Accord 80 mg/4 ml Konzentrat zur Herstellung einer Infusions | Shortage | 2026-06-26 | — | |
| 🇪🇸 ES | DOCETAXEL HIKMA 160 MG/8 ML CONCENTRADO PARA SOLUCION PARA PERFUSION E | Shortage | 2026-05-27 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION | Shortage | 2026-05-20 | 2026-08-30 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | DOCETAXEL ACCORD | Shortage | 2026-05-06 | — | Problemi regolatori |
| 🇮🇹 IT | DOCETAXEL AUROBINDO | Shortage | 2026-04-27 | 2026-07-21 | Problemi produttivi: distribuzione contingentata |
| 🇮🇹 IT | DOCETAXEL ACCORD | Shortage | 2026-04-24 | — | Motivi commerciali |
| 🇪🇸 ES | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION | Shortage | 2026-02-24 | 2026-08-30 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | DOCETAXEL AUROBINDO | Shortage | 2025-10-03 | 2026-07-21 | Problemi produttivi: distribuzione contingentata |
| 🇪🇺 EU | Taxotere (docetaxel) | Resolved | 2016-05-19 | — | Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adeno |
Yes. As of 7 August 2026, availability issues are reported in: Austria, Spain, Greece, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-08-18 to 2026-12-14. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
11 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Docetaxel: BASG (Austria), AEMPS CIMA (Spain), EMA shortages catalogue (EU), EOF limited-availability list (Greece), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Docetaxel — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/docetaxel/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Docetaxel availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/docetaxel/">Docetaxel shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>